A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

Clinical trial NCT06464588 · RECRUITING

Trial details

NCT number: NCT06464588
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Dilated Cardiomyopathy

Start date: 2025-07-14
Primary completion: 2027-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.